Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 19, 2022
Patent Application Number
16958563
Date Filed
December 27, 2018
Patent Citations Received
Patent Primary Examiner
Provided herein are agonistic antibodies, or antigen binding portions thereof, that bind to human CD40 and comprise improved heavy and light chain variable regions that impart improved yield and reduced aggregation. The invention also provides methods of treatment of cancer or chronic infection by administering the antibodies of the invention to a subject in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
